Zhejiang Anglikang Pharmaceutical Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Public

  • Employees
  • 1,236

Employees

  • Stock Symbol
  • 002940

Stock Symbol

  • Investments
  • 7

  • Share Price
  • $3.68
  • (As of Thursday Closing)

Zhejiang Anglikang Pharmaceutical General Information

Description

Zhejiang AngliKang Pharmaceutical Co Ltd is engaged in the manufacturing and sale of pharmaceutical materials, pharmaceutical preparations, and medical empty capsules. The main products offered by the group are cephalosporin antibacterial, angiocarpy drugs, and gastrointestinal tract drugs. Geographically, the activities are carried out in Shengzhou, China.

Contact Information

Website
www.alkpharm.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Number 1000, Shengzhou Avenue North
  • Shengzhou, Zhejiang 312400
  • China
+86 0575
Primary Industry
Pharmaceuticals
Stock Exchange
SHE
Corporate Office
  • Number 1000, Shengzhou Avenue North
  • Shengzhou, Zhejiang 312400
  • China
+86 0575

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zhejiang Anglikang Pharmaceutical Stock Performance

As of 12-Nov-2026, Zhejiang Anglikang Pharmaceutical’s stock price is $3.68. Its current market cap is $743M with 202M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.68 $3.79 $3.06 - $6.87 $743M 202M 11.2M $0.08

Zhejiang Anglikang Pharmaceutical Financials Summary

As of 30-Sep-2026, Zhejiang Anglikang Pharmaceutical has a trailing 12-month revenue of $184M.

In Thousands,
USD 		TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 664,782 953,679 357,340 598,940
Revenue 184,218 198,129 214,325 229,808
EBITDA 21,423 35,691 33,948 39,321
Net Income 16,011 17,443 11,196 19,558
Total Assets 435,588 421,744 407,465 426,035
Total Debt 63,563 64,181 66,481 82,916
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Zhejiang Anglikang Pharmaceutical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Zhejiang Anglikang Pharmaceutical‘s full profile, request access.

Request a free trial

Zhejiang Anglikang Pharmaceutical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Zhejiang Anglikang Pharmaceutical Investments & Acquisitions (7)

Zhejiang Anglikang Pharmaceutical’s most recent deal was a Merger/Acquisition with Kerui Biopharmaceutical for . The deal was made on 27-Mar-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Kerui Biopharmaceutical 27-Mar-2022 Merger/Acquisition Pharmaceuticals
Kerui Biopharmaceutical 15-Mar-2022 Corporate Pharmaceuticals
Kerui Biopharmaceutical 21-Feb-2022 Secondary Transaction - Private Pharmaceuticals
KYF (Pharmaceuticals) 27-Jan-2022 Secondary Transaction - Private Pharmaceuticals
Haichang Biotech 31-Dec-2021 Later Stage VC Biotechnology
You’re viewing 5 of 7 investments and acquisitions. Get the full list »

Zhejiang Anglikang Pharmaceutical ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Zhejiang Anglikang Pharmaceutical’s complete esg history, request access »

Zhejiang Anglikang Pharmaceutical Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Kerui Biopharmaceutical Shaoyang, China 2005

Zhejiang Anglikang Pharmaceutical FAQs

  • When was Zhejiang Anglikang Pharmaceutical founded?

    Zhejiang Anglikang Pharmaceutical was founded in 2001.

  • Where is Zhejiang Anglikang Pharmaceutical headquartered?

    Zhejiang Anglikang Pharmaceutical is headquartered in Shengzhou, China.

  • What is the size of Zhejiang Anglikang Pharmaceutical?

    Zhejiang Anglikang Pharmaceutical has 1,236 total employees.

  • What industry is Zhejiang Anglikang Pharmaceutical in?

    Zhejiang Anglikang Pharmaceutical’s primary industry is Pharmaceuticals.

  • Is Zhejiang Anglikang Pharmaceutical a private or public company?

    Zhejiang Anglikang Pharmaceutical is a Public company.

  • What is Zhejiang Anglikang Pharmaceutical’s stock symbol?

    The ticker symbol for Zhejiang Anglikang Pharmaceutical is 002940.

  • What is the current stock price of Zhejiang Anglikang Pharmaceutical?

    As of 12-Nov-2026 the stock price of Zhejiang Anglikang Pharmaceutical is $3.68.

  • What is the current market cap of Zhejiang Anglikang Pharmaceutical?

    The current market capitalization of Zhejiang Anglikang Pharmaceutical is $743M.

  • What is Zhejiang Anglikang Pharmaceutical’s current revenue?

    The trailing twelve month revenue for Zhejiang Anglikang Pharmaceutical is $184M.

  • What is Zhejiang Anglikang Pharmaceutical’s annual earnings per share (EPS)?

    Zhejiang Anglikang Pharmaceutical’s EPS for 12 months was $0.08.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process